ArticleExpert review of pharmacoeconomics & outcomes research2015

Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland.

Maria Agapova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.